Skye Hung-Chun Cheng

6PUBLICATIONS
41CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 21, 2023
Performance and Operational Feasibility of Epstein-Barr Virus-Based Screening for Detection of Nasopharyngeal Carcinoma: Direct Comparison of Two Alternative Approaches.

Pei-Jen Lou, W K Jacky Lam, Wan-Lun Hsu

|Jul 20, 2023
Looking Back: International Practice Patterns in Breast Radiation Oncology From a Case-Based Survey Across 54 Countries During the First Surge of the COVID-19 Pandemic.

Oluwadamilola T Oladeru, Samantha A Dunn, Jian Li

|Nov 26, 2022
Prognostic Comparison between Oncotype DX® and a 23-Gene Classifier, RecurIndex®, on the Taiwan Breast Cancer Population.

Chuan-Hsun Chang, Po-Sheng Yang, Chia-Ming Hsieh

|Jun 03, 2022
Disparities in Access to Systemic Treatment for Breast Cancer in Thailand and Major Asian Territories.

Suthinee Ithimakin, Napa Parinyanitikul, Sung-Bae Kim

|Jul 20, 2021
Risk evaluation of early-stage hormone receptor-positive and human epidermal growth factor receptor 2-negative breast cancer patients: a population-based study from Taiwan.

Lei Lei, Han-Ching Chan, Tzu-Pin Lu

|Sep 09, 2017
Validation of the 18-gene classifier as a prognostic biomarker of distant metastasis in breast cancer.

Skye Hung-Chun Cheng, Tzu-Ting Huang, Yu-Hao Cheng

Pageof 1

Frequent Collaborators

1 joint publications

Suthinee Ithimakin

1 joint publications

Napa Parinyanitikul

1 joint publications

Sung-Bae Kim

1 joint publications

Yoon-Sim Yap